Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive cancer data study aims to streamline patient care

NCT ID NCT06270602

Knowledge-focused Sponsor: National Cancer Institute, Naples Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is gathering information from 15,000 cancer patients registered on the ROC platform across multiple centers. The goal is to track how quickly patients move through diagnosis, treatment decisions, and care, and to identify where delays or extra costs occur. No new treatments are being tested—this is purely about observing and improving the care process.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. All consecutive patients entered in the ROC platform from the start of platform activation (November 2018) until the date in which the study is approved by the local ethical committee (The retrospective cohort will be made by more than 40000 patients already included in the platform and entered a GOM path. 2. All consecutive patients who enter in the ROC platform as for clinical practice from the date in which the study is approved by the local ethical committee (Investigator is allowed to enroll patients).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * signed informed consent * registration in the ROC platform

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oncology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    17 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O. Cardarelli

    RECRUITING

    Naples, Napoli, 80131, Italy

  • A.O. Dei Colli

    RECRUITING

    Naples, Napoli, 80131, Italy

  • A.O. Moscati

    RECRUITING

    Avellino, Avellino, 83100, Italy

  • A.O. Rummo

    RECRUITING

    Benevento, Benevento, 82100, Italy

  • A.O. S.Anna S. Sebastiano

    RECRUITING

    Caserta, Caserta, 81100, Italy

  • A.O.U. Luigi Vanvitelli

    RECRUITING

    Naples, Napoli, 80138, Italy

  • A.O.U. Ruggi

    RECRUITING

    Salerno, Salerno, 84126, Italy

  • Asl Avellino

    RECRUITING

    Avellino, Avellino, 83100, Italy

  • Asl Benevento

    RECRUITING

    Benevento, Benevento, 82100, Italy

  • Asl Caserta

    RECRUITING

    Caserta, Caserta, 81035, Italy

  • Asl Napoli 1 Centro

    RECRUITING

    Naples, Napoli, 80145, Italy

  • Asl Napoli 2 Nord

    RECRUITING

    Casavatore, Napoli, 80020, Italy

  • Asl Napoli 3 Sud

    RECRUITING

    Ercolano, Napoli, 80056, Italy

  • Asl Salerno

    RECRUITING

    Salerno, Salerno, 84124, Italy

  • Federico II

    RECRUITING

    Naples, Napoli, 80131, Italy

  • I.N.T. Pascale

    RECRUITING

    Naples, Napoli, 80131, Italy

  • Ospedale del Mare

    RECRUITING

    Naples, Napoli, 80147, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.